ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products : CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56^+CD3^- NK cells

• KOEHL U.

  Pediatric Hematology and Oncology, Laboratory of Stem Cell Transplantation and Immunotherapy, University Hospital

• BOCHENNEK K.

  Pediatric Hematology and Oncology, Laboratory of Stem Cell Transplantation and Immunotherapy, University Hospital

• ESSER R.

  Pediatric Hematology and Oncology, Laboratory of Stem Cell Transplantation and Immunotherapy, University Hospital

• BRINKMANN A.

  Pediatric Hematology and Oncology, Laboratory of Stem Cell Transplantation and Immunotherapy, University Hospital

• QUARITSCH R.

  Pediatric Hematology and Oncology, Laboratory of Stem Cell Transplantation and Immunotherapy, University Hospital

• BECKER M.

  Pediatric Hematology and Oncology, University Hospital Frankfurt

• SOERENSEN J.

  Pediatric Hematology and Oncology, University Hospital Frankfurt

• BADER P.

  Pediatric Hematology and Oncology, University Hospital Frankfurt

• SCHWABE D.

  Pediatric Hematology and Oncology, University Hospital Frankfurt

• KLINGEBIEL T.

  Pediatric Hematology and Oncology, University Hospital Frankfurt

• FISCHER J.

  Institute for Diagnostics of Transplantation and Cell Therapy

• ZIMMERMANN S. Y.

  Pediatric Hematology and Oncology, Laboratory of Stem Cell Transplantation and Immunotherapy, University Hospital

収録刊行物

• International journal of hematology

  International journal of hematology 87 (1), 98-105, 2008-01-15

キーワード

• DLI
• Graft engineering
• Residual T cells
• Single-platform method

詳細情報

• CRID: 1572824500440161920
• NII論文ID: 10021255311
• NII書誌ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2008187339
• 本文言語コード: en
• データソース種別:
  • CiNii Articles